search
Back to results

Postoperative Drainage in Total Knee Arthroplasty in the Presence of Tranexamic Acid

Primary Purpose

Osteoarthritis, Knee

Status
Unknown status
Phase
Not Applicable
Locations
Portugal
Study Type
Interventional
Intervention
Drainage of surgical wound
Sponsored by
Hospital Beatriz Ângelo
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Osteoarthritis, Knee focused on measuring Knee replacement, Blood loss, Wound drainage

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Consecutive patients admitted to perform a primary unilateral total knee arthroplasty

Exclusion Criteria:

  • Contraindication to take tranexamic acid
  • hematologic disease with a higher risk of bleeding
  • abnormal coagulation tests
  • refusal of blood transfusions
  • inadequate preoperatory optimization
  • deformity >15⁰ of varus or valgus

Sites / Locations

  • Hospital Beatriz AngeloRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

With drain

Without drain

Arm Description

Participants who received a drain during surgery

Participants who did not receive a drain during surgery

Outcomes

Primary Outcome Measures

Total RBC loss
Total red blood cells loss after surgery
Total RBC loss
Total red blood cells loss after surgery
Total RBC loss
Total red blood cells loss after surgery
Blood transfusion requirements
Blood transfusions requirements
Knee Society Score score
Knee Society Score measuring function of Knee (0-100 total score, higher values, better outcome)

Secondary Outcome Measures

Haematocrit level
Haematocrit level
Haematocrit level
Haematocrit level
Haematocrit level
Haematocrit level
Haemoglobin level
Haemoglobin level
Haemoglobin level
Haemoglobin level
Haemoglobin level
Haemoglobin level
Surgery duration
Surgery duration (min)
Length of skin incision
Length of skin incision
Tourniquet duration
Tourniquet duration (min)
Surgical blood loss
Surgical blood loss (mL)
Iron
Iron products used
Transfusion reactions
Transfusion reactions
Drain volume
Drain volume (mL)
MKC
Midpatellar Knee Circumference (cm)
MKC
Midpatellar Knee Circumference (cm)
MKC
Midpatellar Knee Circumference (cm)
ROM
Range of motion (°)
ROM
Range of motion (°)
ROM
Range of motion (°)
Fluidotherapy excess
Fluidotherapy excess (mL)
Wound complications (i. e., wound dehiscence, infection)
Wound complications (i. e., wound dehiscence, infection)
Lower leg deep vein thrombosis
Lower leg deep vein thrombosis

Full Information

First Posted
April 12, 2019
Last Updated
February 12, 2021
Sponsor
Hospital Beatriz Ângelo
search

1. Study Identification

Unique Protocol Identification Number
NCT03915756
Brief Title
Postoperative Drainage in Total Knee Arthroplasty in the Presence of Tranexamic Acid
Official Title
Postoperative Drainage in Total Knee Arthroplasty in the Presence of Tranexamic Acid: a Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
February 2021
Overall Recruitment Status
Unknown status
Study Start Date
August 22, 2019 (Actual)
Primary Completion Date
May 2022 (Anticipated)
Study Completion Date
July 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Hospital Beatriz Ângelo

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The investigator's aim with this study is to address, with the new paradigm of tranexamic acid, the role of wound drainage following total knee arthroplasty in blood loss, blood transfusion requirements and functional recovery
Detailed Description
All participants will attend a preoperatory appointment with an anaesthesiologist where preoperative haemoglobin will be optimized (Hg > 13 g/L). Randomization will be done by opening a closed envelop with the selected group from a bag at the time of wound closure. Collected preoperative information will include age, gender, weight, height, body-mass index, underlying diseases, operated side, haematocrit, haemoglobin level, midpatellar knee circumference and range of movement. Blood work was performed within 1 hour of the beginning of the surgery. Clinical parameters will be collected before anaesthesia. In all cases, the surgeon will perform a medial parapatellar approach with a standard incision with the participants in the supine position. The SIGMA PFC total knee system (DePuy, Warsaw, In) and its posterior-stabilized design with a rotatory platform will be used. All participants will be under a subarachnoid spinal block. A tourniquet will be used (pressure of 350 mmHg) from the beginning of the surgery and deflated for haemostasis before wound closure. At this time, before complete water-tight fascial closure, the patients will be allocated to group With or Without drain as described, and a drain will be placed in a subfascial position. The drain will be left clamped for 1 hour and will be left in place for 24 hours. Compressive dressings will be applied at the end of the surgery. Continuous passive motion will be started within 24 hours of surgery (0-60°, progressing as tolerated). In all participants, about 30min before tourniquet release, intravenous tranexamic acid will be used with an initial bolus of 10 mg/kg administered in 10min followed by a perfusion of 10mg/kg over 4h. For postoperative analgesia, a femoral triangle and a popliteal block (anterior approach) will be done in all participants. A standard fluid therapy of a balanced crystalloid solution (perfusion 10ml/kg/h) will be administered to all patients. After tourniquet release, during haemostasis and in the recovery room, an eventual need of increasing fluid therapy perfusion or a bolus will be noted in the patient's file. Hidden blood loss will be calculated according to the haemoglobin balance method as it suggested to be the most reliable method. Total blood volume will be calculated as described by Nadler et al. The normality of the data will be tested with the Shapiro-Wilk test/Kolmogorov-Smirnov test. The data will be compared and analyzed using Student's t-test for independent samples, or the Mann-Whitney test, according to the normality of the data. The correlation of data will be analyzed with the Pearson or Spearman correlation coefficient according to its normality. Nominal variables will be compared using the chi-square test. P-values less than 0.05 will be considered significant. Dedicated statistical software (SPSS version 21, SPSS Inc., Chicago, USA) will be used.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Osteoarthritis, Knee
Keywords
Knee replacement, Blood loss, Wound drainage

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
42 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
With drain
Arm Type
Experimental
Arm Description
Participants who received a drain during surgery
Arm Title
Without drain
Arm Type
No Intervention
Arm Description
Participants who did not receive a drain during surgery
Intervention Type
Procedure
Intervention Name(s)
Drainage of surgical wound
Intervention Description
Introduction of a drain before full fascial closure
Primary Outcome Measure Information:
Title
Total RBC loss
Description
Total red blood cells loss after surgery
Time Frame
96 hours
Title
Total RBC loss
Description
Total red blood cells loss after surgery
Time Frame
24 hours
Title
Total RBC loss
Description
Total red blood cells loss after surgery
Time Frame
1 hour
Title
Blood transfusion requirements
Description
Blood transfusions requirements
Time Frame
96 hours
Title
Knee Society Score score
Description
Knee Society Score measuring function of Knee (0-100 total score, higher values, better outcome)
Time Frame
14 days
Secondary Outcome Measure Information:
Title
Haematocrit level
Description
Haematocrit level
Time Frame
1 hour
Title
Haematocrit level
Description
Haematocrit level
Time Frame
24 hours
Title
Haematocrit level
Description
Haematocrit level
Time Frame
96 hours
Title
Haemoglobin level
Description
Haemoglobin level
Time Frame
1 hour
Title
Haemoglobin level
Description
Haemoglobin level
Time Frame
24 hours
Title
Haemoglobin level
Description
Haemoglobin level
Time Frame
96 hours
Title
Surgery duration
Description
Surgery duration (min)
Time Frame
0hour
Title
Length of skin incision
Description
Length of skin incision
Time Frame
0 hour
Title
Tourniquet duration
Description
Tourniquet duration (min)
Time Frame
0 hour
Title
Surgical blood loss
Description
Surgical blood loss (mL)
Time Frame
0 hour
Title
Iron
Description
Iron products used
Time Frame
96 hours
Title
Transfusion reactions
Description
Transfusion reactions
Time Frame
96 hours
Title
Drain volume
Description
Drain volume (mL)
Time Frame
24 hours
Title
MKC
Description
Midpatellar Knee Circumference (cm)
Time Frame
48 hours
Title
MKC
Description
Midpatellar Knee Circumference (cm)
Time Frame
96 hours
Title
MKC
Description
Midpatellar Knee Circumference (cm)
Time Frame
14 days
Title
ROM
Description
Range of motion (°)
Time Frame
48 hours
Title
ROM
Description
Range of motion (°)
Time Frame
96 hours
Title
ROM
Description
Range of motion (°)
Time Frame
14 days
Title
Fluidotherapy excess
Description
Fluidotherapy excess (mL)
Time Frame
96 hours
Title
Wound complications (i. e., wound dehiscence, infection)
Description
Wound complications (i. e., wound dehiscence, infection)
Time Frame
14 days
Title
Lower leg deep vein thrombosis
Description
Lower leg deep vein thrombosis
Time Frame
14 days

10. Eligibility

Sex
All
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Consecutive patients admitted to perform a primary unilateral total knee arthroplasty Exclusion Criteria: Contraindication to take tranexamic acid hematologic disease with a higher risk of bleeding abnormal coagulation tests refusal of blood transfusions inadequate preoperatory optimization deformity >15⁰ of varus or valgus
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Afonso Cardoso
Phone
00351918972882
Email
afonso.cardoso@hbeatrizangelo.pt
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Afonso Cardoso
Organizational Affiliation
Hospital Beatriz Angelo
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hospital Beatriz Angelo
City
Loures
ZIP/Postal Code
2674-514
Country
Portugal
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Afonso Cardoso
Phone
00351918972882
Email
afonso.cardoso@hbeatrizangelo.pt

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
24553908
Citation
Cross M, Smith E, Hoy D, Nolte S, Ackerman I, Fransen M, Bridgett L, Williams S, Guillemin F, Hill CL, Laslett LL, Jones G, Cicuttini F, Osborne R, Vos T, Buchbinder R, Woolf A, March L. The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014 Jul;73(7):1323-30. doi: 10.1136/annrheumdis-2013-204763. Epub 2014 Feb 19.
Results Reference
background
PubMed Identifier
15173310
Citation
NIH Consensus Panel. NIH Consensus Statement on total knee replacement December 8-10, 2003. J Bone Joint Surg Am. 2004 Jun;86(6):1328-35. doi: 10.2106/00004623-200406000-00031. No abstract available.
Results Reference
background
PubMed Identifier
24122437
Citation
Banerjee S, Kapadia BH, Issa K, McElroy MJ, Khanuja HS, Harwin SF, Mont MA. Postoperative blood loss prevention in total knee arthroplasty. J Knee Surg. 2013 Dec;26(6):395-400. doi: 10.1055/s-0033-1357491. Epub 2013 Oct 11.
Results Reference
background
PubMed Identifier
26961597
Citation
Huang GP, Jia XF, Xiang Z, Ji Y, Wu GY, Tang Y, Li J, Zhang J. Tranexamic Acid Reduces Hidden Blood Loss in Patients Undergoing Total Knee Arthroplasty: A Comparative Study and Meta-Analysis. Med Sci Monit. 2016 Mar 10;22:797-802. doi: 10.12659/msm.895571.
Results Reference
background
PubMed Identifier
25450009
Citation
Wang H, Shen B, Zeng Y. Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials. Knee. 2014 Dec;21(6):987-93. doi: 10.1016/j.knee.2014.09.010. Epub 2014 Oct 23.
Results Reference
background
PubMed Identifier
28658157
Citation
Zhang Y, Zhang JW, Wang BH. Efficacy of tranexamic acid plus drain-clamping to reduce blood loss in total knee arthroplasty: A meta-analysis. Medicine (Baltimore). 2017 Jun;96(26):e7363. doi: 10.1097/MD.0000000000007363.
Results Reference
background
PubMed Identifier
29408472
Citation
Liao L, Chen Y, Tang Q, Chen YY, Wang WC. Tranexamic acid plus drain-clamping can reduce blood loss in total knee arthroplasty: A systematic review and meta-analysis. Int J Surg. 2018 Apr;52:334-341. doi: 10.1016/j.ijsu.2018.01.040. Epub 2018 Feb 3.
Results Reference
background
PubMed Identifier
23494778
Citation
Craik JD, Ei Shafie SA, Kidd AG, Twyman RS. Can local administration of tranexamic acid during total knee arthroplasty reduce blood loss and transfusion requirements in the absence of surgical drains? Eur J Orthop Surg Traumatol. 2014 Apr;24(3):379-84. doi: 10.1007/s00590-013-1206-1. Epub 2013 Mar 14.
Results Reference
background
PubMed Identifier
24816760
Citation
Yang Y, Lv YM, Ding PJ, Li J, Ying-Ze Z. The reduction in blood loss with intra-articular injection of tranexamic acid in unilateral total knee arthroplasty without operative drains: a randomized controlled trial. Eur J Orthop Surg Traumatol. 2015 Jan;25(1):135-9. doi: 10.1007/s00590-014-1461-9. Epub 2014 May 10.
Results Reference
background
PubMed Identifier
26521781
Citation
Gao FQ, Li ZJ, Zhang K, Sun W, Zhang H. Four Methods for Calculating Blood-loss after Total Knee Arthroplasty. Chin Med J (Engl). 2015 Nov 5;128(21):2856-60. doi: 10.4103/0366-6999.168041.
Results Reference
background
PubMed Identifier
21936146
Citation
Nadler SB, Hidalgo JH, Bloch T. Prediction of blood volume in normal human adults. Surgery. 1962 Feb;51(2):224-32. No abstract available.
Results Reference
background

Learn more about this trial

Postoperative Drainage in Total Knee Arthroplasty in the Presence of Tranexamic Acid

We'll reach out to this number within 24 hrs